Received Apr 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
Provider requesting information on administering a second dose of GARDASIL 9 to a patient. She states that the patient received their first dose 2/21/2020 when she was 13 years old. She is now requesting to finish the series. No additional AE, no PQC; No additional AE; This spontaneous report has been received from a physician regarding a female patient of unknown age. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 21-FEB-2020, when the patient was 13 years old, she was vaccinated with the first dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), administered as prophylaxis (strength, dose, route of administration, anatomical site of injection, lot number, and expiration date were not reported). The patient is now requesting to finish the series, and the healthcare provider requested information on administering the second dose (Inappropriate schedule of product administration). No additional adverse event was reported.